Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (20)

1

Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials

enthalten in: Journal of medical virology | 2021

von Lathouwers, E. | Weinsteiger, S. | Baugh, B. | +5

2

Lack of antiviral activity of darunavir against SARS-CoV-2

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von De Meyer, S. | Bojkova, D. | Cinatl, J. | +5

3

Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection

enthalten in: HIV research & clinical practice | 2020

von Lathouwers, E. | Seyedkazemi, S. | Luo, D. | +3

4

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

enthalten in: AIDS research and human retroviruses | 2020

von Lathouwers, E. | Wong, E. | Brown, K. | +108

5

HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studies

enthalten in: HIV clinical trials | 2017

von Lathouwers, E. | Wong, E. | Luo, D. | +3

6

Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012

enthalten in: AIDS research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3

7

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients

enthalten in: Antiviral therapy | 2013

von Lathouwers, E. | De La Rosa, G. | Van de Casteele, T. | +4

8

Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN

enthalten in: Current HIV research | 2012

von Bánhegyi, D. | Katlama, C. | da Cunha, C. | +7

9

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

10

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients

enthalten in: Antiviral therapy | 2010

von Dierynck, I. | De Meyer, S. | Lathouwers, E. | +5